Penetrating Keratoplasty Segment to Lead Global Corneal Transplantation Market during 2021–2028
According to our new research study on “Corneal Transplantation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Indication, and End User,” the market is expected to grow from US$ 420.71 million in 2021 to US$ 640.79 million by 2028, it is estimated to grow at a CAGR of 6.2% during 2021–2028. Factors driving the growth of the market are the increasing incidence of eye diseases and surge in geriatric population.
Based on type, the Corneal Transplantation market is segmented into single use penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. The penetrating keratoplasty segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. Penetrating keratoplasty (PK) is a full-thickness grafting procedure. PK has emerged as a safe and effective procedure. Penetrating keratoplasty (PK) is performed for various reasons related to multiple medical conditions that patients suffer from.
Impact of COVID-19 Pandemic on Corneal Transplantation Market
The global economy was severely affected due to the COVID-19 cases in the region. The rising occurrence rate of coronavirus results in increased stress on the region's healthcare system. During the COVID-19 pandemic, outpatient appointments were avoided as far as possible. This increases the risk of infection for both the patient and the medical staff running the clinic. The COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. There has been a shift of priorities from eye disease treatment to COVID-19 diagnosis and treatment devices is leading to a decline in market growth up to a certain extent. Many hospitals and surgical centers had considered cancelling or postponing elective surgeries, including corneal transplantation procedures due to COVID-19. The COVID-19 emergency has undoubtedly aided in encouraging the general population to try out and expand their usage of digital services, particularly to avoid having to visit a health center in person. Corneal donation and transplantation activity dropped substantially when COVID-19 spread rapidly across various regions. Hence, the COVID 19 had somewhat negative impact on the corneal transplantation market before the introduction of COVID-19 vaccine.CorneaGen, Alcon Inc., Florida Lions Eye Bank, Corneat Vision, Aurolab, Keramed, Inc., Cornea Biosciences, Inc., Eyemedics, Massachusetts Eye and Ear, Lifeline Scientific, Inc.; and San Diego Eye Bank are among the leading companies operating in the Corneal Transplantation market.
Corneal Transplantation Market, by Region, 2021 (%)
Corneal Transplantation Market Size & Analysis | Report 2028
Download Free Sample
Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Penetrating Keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and Others), Indication (Fungal Corneal Ulcer, Fuchs Dystrophy, Keratoconus, Keratitis, and Others) End User (Hospitals, Eye Clinic, and Ambulatory Surgical Centers)
Corneal Transplantation Market Size & Analysis | Report 2028
Download Free SampleCorneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Penetrating Keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and Others), Indication (Fungal Corneal Ulcer, Fuchs Dystrophy, Keratoconus, Keratitis, and Others) End User (Hospitals, Eye Clinic, and Ambulatory Surgical Centers)
Based on type, Corneal Transplantation market is segmented into penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. Based on indication the market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. Based on end user, the market is segmented into hospitals, eye clinics, and ambulatory surgical centers. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com